Loading...
menu
Search
AI Trading Bot
Features
Markets
News
Resources
Pricing
Get Started
Home
ETF
DXCM
DXCM
-
Add to Watchlist
$
0.000
0.000
(
0.000%
)
At close
0.000
(
0.000%
)
Aft-market
ET
$
0.000
0.000
(
0.000%
)
At close
0.000
(
0.000%
)
Aft-market
ET
Overview
Technical
News
DXCM News
Abbott's Q2 Earnings Preview and Growth Drivers
26m ago
Fool
Abbott's Diversified Business Fuels Growth
28m ago
NASDAQ.COM
FDA Approves DexCom's OTC Glucose Monitor for Children
Jun 12 2026
seekingalpha
Dexcom CONNECT Trial Significantly Improves Glucose Control in Type 2 Diabetes Patients
Jun 06 2026
Newsfilter
Dexcom CONNECT Trial Significantly Improves Glucose Control in Type 2 Diabetes Patients
Jun 06 2026
Yahoo Finance
Competitive Analysis of Diabetes Monitoring Market
Jun 04 2026
NASDAQ.COM
Comparative Analysis of Diabetes Management Innovations
Jun 04 2026
Fool
Dexcom Unveils Key Findings at ADA Conference
Jun 04 2026
Newsfilter
Investment Opportunities in Meta and Dexcom Amid Market Volatility
Jun 02 2026
Fool
Dexcom Establishes Permanent Council to Drive Innovation
Jun 02 2026
Newsfilter
Snowflake Reports Strong Q1 Results, Shares Surge 37%
May 28 2026
CNBC
Oil Prices Rise Amid Geopolitical Tensions and Strong Tech Earnings
May 28 2026
Newsfilter
Signos Secures $20 Million Funding to Expand Market Presence
May 27 2026
CNBC
Signos Secures $20 Million Funding and Expands Partnership with Dexcom
May 27 2026
Newsfilter
DexCom Reports Theft of Condemned G7 Devices
May 26 2026
NASDAQ.COM
DexCom G7 Sensors Stolen and Resold by Unauthorized Distributors
May 26 2026
seekingalpha
Show More News
